Through this mechanism, GAS5 overexpression has been shown to promote apoptosis in breast cancer cells [134] and increase basal and drug-induced apoptosis in prostate cancer cells, while GAS5 downregulation attenuates apoptosis [135]. This evidence concerns the gene GAS5 and prostate carcinoma.